Sanofi Consumer Healthcare India (NSE:SANOFICONR) Quick Ratio: 0.00 (As of Mar. 2026)


NSE:SANOFICONR Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
32 GF Score
Price ₹4,601.70
! 2 Warning Signs
View Full Analysis

What is Sanofi Consumer Healthcare India Quick Ratio?

Sanofi Consumer Healthcare India NSE:SANOFICONR -0.50% 32 Quick Ratio is 0.00 as of Mar. 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 996 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 79.52% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Sanofi Consumer Healthcare India's quick ratio for the quarter that ended in Mar. 2026 was 0.00.

Sanofi Consumer Healthcare India has a quick ratio of 0.00. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Sanofi Consumer Healthcare India's Quick Ratio or its related term are showing as below:

NSE:SANOFICONR' s Quick Ratio Range Over the Past 10 Years
Min: 1.84   Med: 2.43   Max: 3.37
Current: 3.37

During the past 3 years, Sanofi Consumer Healthcare India's highest Quick Ratio was 3.37. The lowest was 1.84. And the median was 2.43.

NSE:SANOFICONR's Quick Ratio is ranked better than
79.52% of 996 companies
in the Drug Manufacturers industry
Industry Median: 1.45 vs NSE:SANOFICONR: 3.37

Sanofi Consumer Healthcare India  (NSE:SANOFICONR) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Sanofi Consumer Healthcare India Quick Ratio Related Terms


Sanofi Consumer Healthcare India Quick Ratio Historical Data

* Premium members only.

The historical data trend for Sanofi Consumer Healthcare India's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India Quick Ratio Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24 Dec25
Quick Ratio
1.84 2.69 3.37

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 2.17 0.00 3.37 0.00

NSE:SANOFICONR vs LLY, JNJ, ABBV: Quick Ratio Comparison

For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi Consumer Healthcare India Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Sanofi Consumer Healthcare India's Quick Ratio falls into.


NSE:SANOFICONR
32GF Score
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Consumer Healthcare India Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Sanofi Consumer Healthcare India's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(4943-619)/1284
=3.37

Sanofi Consumer Healthcare India's Quick Ratio for the quarter that ended in Mar. 2026 is calculated as

Quick Ratio (Q: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0-0)/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.00 mean?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Quick Ratio of 0.00 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sanofi Consumer Healthcare India and its competitors. Over the past decade, Sanofi Consumer Healthcare India's Quick Ratio has ranged from 1.84 to 3.37. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #204 out of 996 companies in the Drug Manufacturers industry, placing it in the top 20.5%.
Is Sanofi Consumer Healthcare India's Quick Ratio too high?
Sanofi Consumer Healthcare India's current Quick Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 1.84 to a high of 3.37. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #204 out of 996 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Quick Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #204 out of 996 companies for Quick Ratio. This places Sanofi Consumer Healthcare India in the top 21% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Historically, Sanofi Consumer Healthcare India's own Quick Ratio has ranged from 1.84 to 3.37 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Quick Ratio of 0.00. The current Quick Ratio is 0.00. Sanofi Consumer Healthcare India's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Quick Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sanofi Consumer Healthcare India Business Description

Other Exchanges 544250:India
Address Pirojshanagar, Eastern Express Highway, Unit 1104, 11th Floor, Godrej Two, Vikhroli East, Mumbai, MH, IND, 400079
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
32GF Score

Get the complete analysis for NSE:SANOFICONR

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,601.70
Price